STLNW — Starling Oncology, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1799191 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 161,282,000 | 193,063,000 | -4,616,000 | -9,789,000 | 178,233,000 | — | 203,147,000 |
| Mar 2026 | 147,441,000 | 180,571,000 | -6,513,000 | -2,492,000 | 168,230,000 | — | 184,515,000 |
| Sep 2025 | 136,564,000 | 163,538,000 | -8,054,000 | -16,504,000 | 163,619,000 | — | 175,893,000 |
| Jun 2025 | 119,802,000 | 148,514,000 | -11,211,000 | -17,009,000 | 159,798,000 | — | 168,783,000 |
Yahoo Snapshot (yfinance, live)
Total Revenue
$620,446,976
EBITDA
$-14,410,000
Free Cash Flow
$29,539,624
Enterprise Value
—
Total Cash
$36,895,000
Total Debt
$102,755,000
Shares Out
—
Trailing EPS
—
Book Value
$-0.37
ROE
—
ROA
-7.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 6y)
Revenues vs Net Income (last 6y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 502,729,000 | -36,083,000 | -60,606,000 | 164,656,000 | 180,376,000 | -15,720,000 | — |
| Dec 2024 | 393,412,000 | -60,118,000 | -64,663,000 | 172,717,000 | 169,128,000 | 3,589,000 | — |
| Dec 2023 | 324,239,000 | -77,018,000 | -83,068,000 | 209,240,000 | 152,215,000 | 57,025,000 | — |
| Dec 2022 | 252,483,000 | -81,951,000 | 152,000 | 261,665,000 | 138,490,000 | 123,175,000 | — |
| Dec 2021 | 203,003,000 | -45,858,000 | -10,927,000 | 203,439,000 | 99,280,000 | 104,159,000 | — |
| Dec 2020 | 254,149 | -683,869 | -441,154 | 231,323,610 | 6,567,550 | 224,756,060 | — |
TTM Snapshot
Revenues TTM
$587,244,000
NetIncome TTM
$-36,293,000
OpCashFlow TTM
—
Assets (Latest)
$178,233,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HCA | HCA Healthcare, Inc. | $104.69B | $501.19 | — |
| NTRA | Natera, Inc. | $41.68B | $287.47 | — |
| LH | LABCORP HOLDINGS INC. | $29.90B | $368.24 | — |
| DGX | QUEST DIAGNOSTICS INC | $28.29B | $256.35 | — |
| THC | TENET HEALTHCARE CORP | $22.45B | $282.07 | — |
News headlines (Yahoo Finance, 1h cache)
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
2026-08-17 12:00 · Yahoo
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
2026-08-06 20:14 · Yahoo
Oncology Institute Q3 Earnings Call Highlights
2026-11-06 14:14 · Yahoo
Starling Oncology, Inc. (STLN) Reports Q3 Loss, Beats Revenue Estimates
2026-11-05 21:45 · Yahoo
Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
2026-11-05 21:06 · Yahoo
Geron (GERN) Reports Break-Even Earnings for Q3
2026-11-04 12:55 · Yahoo
Ultragenyx (RARE) Reports Q3 Loss, Lags Revenue Estimates
2026-11-03 21:50 · Yahoo
Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
2026-10-26 13:00 · Yahoo
Starling Oncology (STLN) Stock Gets Fair Value Boost On Capitated Revenue And Nexus Views
2026-10-15 23:22 · Yahoo
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
2026-10-01 20:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.